https://sermonixpharma.com/wp-content/uploads/2019/12/cropped-sermonix.jpg
cropped-sermonix.jpg
Recent Posts
- Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium
- Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete Remission in a Metastatic Breast Cancer Patient Participating in ELAINE-1 Trial
- Sermonix Pharmaceuticals Announces Results of ELAINE-1 Exploratory Analysis Evaluating Effect of Patient Characteristics on Baseline Genitourinary Symptoms
- Sermonix Pharmaceuticals Shares Results of EQUALS 2 Survey on Vaginal and Sexual Health in Patients with ER+/HER2- Metastatic Breast Cancer
- Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer Research Conference
Archives
- November 2023
- October 2023
- September 2023
- June 2023
- May 2023
- March 2023
- February 2023
- December 2022
- November 2022
- September 2022
- August 2022
- June 2022
- April 2022
- February 2022
- December 2021
- November 2021
- June 2021
- May 2021
- April 2021
- January 2021
- December 2020
- October 2020
- September 2020
- July 2020
- June 2020
- December 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
Recent Comments